Interdisciplinary management of Duchenne muscular dystrophy patients on daily glucocorticoid treatment: Maximizing functional outcomes and minimizing glucocorticoid side effects.

Wong B.; Rybalsky I.; Shellenbarger K.; Tian C.; McMahon M.; Rutter M.; Sawnani H.; Jefferies J.

首页> 外文期刊>Neuromuscular disorders: NMD >Interdisciplinary management of Duchenne muscular dystrophy patients on daily glucocorticoid treatment: Maximizing functional outcomes and minimizing glucocorticoid side effects.

【24h】

Interdisciplinary management of Duchenne muscular dystrophy patients on daily glucocorticoid treatment: Maximizing functional outcomes and minimizing glucocorticoid side effects.

机译：每天进行糖皮质激素治疗的杜兴氏肌营养不良患者的跨学科管理：最大限度地提高功能结果并最小化糖皮质激素的副作用。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neuromuscular disorders: NMD》 |2016年第2期|共2页
作者
Wong B.; Rybalsky I.; Shellenbarger K.; Tian C.; McMahon M.; Rutter M.; Sawnani H.; Jefferies J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献
专利

1. Interdisciplinary management of Duchenne muscular dystrophy patients on daily glucocorticoid treatment: Maximizing functional outcomes and minimizing glucocorticoid side effects. [J] . Wong B., Rybalsky I., Shellenbarger K., Neuromuscular disorders: NMD . 2016,第Suppla2期

机译：每天进行糖皮质激素治疗的杜兴氏肌营养不良患者的跨学科管理：最大限度地提高功能结果并最小化糖皮质激素的副作用。
2. Effects of glucocorticoid treatment in an adult population of Duchenne muscular dystrophy patients attending the neuromuscular complex care centre: An observational study [J] . Desikan M., Nastasi L., Quattrochi G., Neuromuscular disorders: NMD . 2016,第Suppla2期

机译：糖皮质激素治疗对参加神经肌肉综合治疗中心的成年杜兴肌营养不良患者的影响：一项观察性研究
3. The evaluation of bone age in patients with Duchenne muscular dystrophy on long-term glucocorticoid treatment [J] . Annexstad E., Westvik J., Myhre A., Neuromuscular disorders: NMD . 2015,第Suppla2期

机译：长期糖皮质激素治疗对杜氏肌营养不良患者骨龄的评估
4. Identification of User Requirements for Assistive Technology for Support of Upper Limb Daily Life Interactions from Stroke and Duchenne Muscular Dystrophy Patients [C] . Anne L. van Ommeren, Mario Iodice, Marion Main, International Conference on eHealth, Telemedicine, and Social Medicine . 2018

机译：识别用户要求辅助技术支持中肢和Duchenne肌营养不良患者的上肢日常生活相互作用
5. Potential Therapies for Bone Health in Glucocorticoid-Treated Mdx Mouse Model of Duchenne Muscular Dystrophy [D] . Yoon, Sung-Hee Seanna. 2019

机译：糖皮质激素处理的MDX小鼠模型骨骼健康的潜在疗法，Duchenne肌营养不良
6. Description of a Novel Mechanism Possibly Explaining the Antiproliferative Properties of Glucocorticoids in Duchenne Muscular Dystrophy Fibroblasts Based on Glucocorticoid Receptor GR and NFAT5 [O] . Sandrine Herbelet, Boel De Paepe, Jan L. De Bleecker 2020

机译：一种新的机制可能在糖皮质激素受体GR和NFAT5基于糖皮质激素受体GR和NFAT5解释Duchenne肌营养不良成纤维细胞中糖皮质激素的抗增殖性质
7. Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review) [O] . Tianyuan Zhang, Xiangdong Kong 2021

机译：糖皮质激素在杜松龄肌营养不良治疗中的最新进展（审查）

Interdisciplinary management of Duchenne muscular dystrophy patients on daily glucocorticoid treatment: Maximizing functional outcomes and minimizing glucocorticoid side effects.

著录项

相似文献

相关主题

期刊订阅